EVALUATION OF A RESORBABLE COLLAGEN TEMPLATE

Information

  • Research Project
  • 2080817
  • ApplicationId
    2080817
  • Core Project Number
    R43AR041596
  • Full Project Number
    1R43AR041596-01A1
  • Serial Number
    41596
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/20/1993 - 31 years ago
  • Project End Date
    3/19/1994 - 30 years ago
  • Program Officer Name
  • Budget Start Date
    9/20/1993 - 31 years ago
  • Budget End Date
    3/19/1994 - 30 years ago
  • Fiscal Year
    1993
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    9/15/1993 - 31 years ago
Organizations

EVALUATION OF A RESORBABLE COLLAGEN TEMPLATE

The goal of this research is to test the efficacy of a collagen meniscus template to promote host meniscal fibrocartilage regeneration. The template is non-toxic and biodegradable and is fabricated from natural connective tissue components. In earlier studies, the potential of this template to support meniscal cartilage regeneration was shown. Phase I will evaluate the degradation rate of an improved version of the template in rabbit stifles and test the template in a dog model. Phase II will concentrate on larger numbers of animals for statistical analysis of a direct comparison between the collagen meniscus template and conventional meniscal resection. Specific Aim 1 will focus on the optimization, production, and quality control testing of the improved collagen meniscus template. Specific Aim II will measure the template's degradation rate in the rabbit stifle. Specific Aim III will evaluate the performance of the template in the canine stifle. Using anatomic, biochemical and physico-chemical techniques, we will quantify and directly compare current standard meniscal resection alone to the new collagen meniscus template. Potential commercial application of an effective meniscal fibrocartilage template can be appreciated from U.S. Bureau of Health Statistics (1986) estimates that currently more than 1.4 million operations related to meniscus injuries and degenerative arthritis are performed in the United States. Accumulated experimental and clinical data have demonstrated that the abnormal force distribution on the tibial plateau post meniscectomy has led to early degenerative arthritis. No accepted treatment except excision for the irreparably damaged meniscus exists necessitating technological innovation in the practice of clinical orthopaedics for meniscus repair.

IC Name
NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES
  • Activity
    R43
  • Administering IC
    AR
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    846
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SSS
  • Study Section Name
  • Organization Name
    COLLAGEN MATRIX, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    FRANKLIN LAKES
  • Organization State
    NJ
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    07417
  • Organization District
    UNITED STATES